cancer, chemotherapy, nitrogen-containing bisphosphonates, FPPS inhibitors, photo-responsive prodrugs
photodynamic therapy, folate receptor alpha, PARP inhibitors resistance, Ovarian cancer, patient-derived tumor organoids